What Canary Speech does

Canary Speech, Inc. is a privately held AI health technology company incorporated in Delaware and headquartered in Provo, Utah, that builds vocal biomarker software to detect cognitive and behavioral health conditions from short speech samples. Its platform extracts over 2,500 acoustic, prosodic, and linguistic features (including MFCC, pitch, jitter, shimmer, harmonics-to-noise ratio, filler ratios, and out-of-vocabulary metrics) from as little as 20–40 seconds of conversational speech and applies machine learning models, including deep neural networks and patented paired neural network architectures, to screen for anxiety, depression, mild cognitive impairment, Alzheimer's disease, Huntington's disease, Parkinson's disease, and multiple sclerosis. The product portfolio is organized around a core Wellness API and includes the flagship Canary Ambient™ ambient listening tool (real-time, millisecond processing with reported 98% accuracy), modular condition-specific offerings (Canary Behavioral, Canary Cognitive, Canary Safety, Canary Wellness), Canary Express for rapid developer integration, and consumer-facing iOS and Android apps including a free 45-second voice check-in.

The company sells primarily to enterprise buyers through a multi-channel go-to-market model: direct enterprise sales gated by a "Request a Demo" funnel, an API-first self-serve developer motion, listings on the Microsoft Marketplace (Dragon Copilot, reaching 100,000+ clinicians across 9 countries) and Zoom App Marketplace, an authorized reseller relationship with GlobalMed for U.S. federal healthcare systems, and an embedded integration with Teladoc Health. Revenue derives from subscription/recurring enterprise API and platform licensing, channel and reseller margins, CPT-reimbursable clinical encounters under 13 AAPC-approved codes (ranging $2.33 to $272.62 per patient visit), marketplace transaction fees, and freemium consumer tools that funnel into enterprise offerings. Canary Speech has raised approximately $22.3 million in cumulative disclosed funding, holds a multi-jurisdiction patent portfolio of 25+ granted and pending patents across the U.S., Europe, Japan, and Hong Kong, and is HIPAA-compliant, HITRUST e1 certified, and ISO/IEC 27001:2022 and ISO/IEC 42001:2023 certified — positioning it as a clinically validated, enterprise-grade vendor for voice-based clinical decision support.

Name

Canary Speech

Legal name

Canary Speech, Inc.

Website

https://canaryspeech.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Canary Speech builds API-first AI vocal biomarker software that detects cognitive and behavioral health conditions from short speech samples, serving healthcare providers, payers, clinical trials, contact centers, and consumer health through its Wellness API, Canary Ambient ambient listening platform, and Microsoft/Zoom marketplace integrations.

Ownership category

akta.pro rank

Product category

Vocal Biomarker Software / Clinical AI Voice Analysis

NAICS

Sound Recording Industries (5122)

akta.pro primary industry

Behavioral Health & Substance Use Remote Monitoring (HLACAFAD)

akta.pro secondary industry

Audio & Speech Analytics (call analytics, QA, insights) (HDAAAFAH)

Keywords

• Vocal biomarker software
• Clinical voice analysis
• Ambient AI healthcare
• Behavioral health screening
• Speech AI platform

Headquarters

HQ city

Provo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Enterprise API & Platform Licensing: Recurring revenue from enterprise customers (health systems, payers, contact centers, clinical trials) accessing Canary's vocal biomarker API and platform (Canary Ambient™). Custom/quote-based enterprise contracts.
2. CPT Reimbursement-Enabled Clinical Services: Provider-side reimbursable screening encounters under CPT codes 96127, 96146, 96112, 96125 (13 AAPC-approved CPT codes ranging from $2.33 to $272.62 per patient visit), enabling health systems and clinicians to monetize Canary-driven assessments.
3. Channel Reseller / Federal Healthcare: Reseller margin from authorized reseller GlobalMed, which distributes Canary Speech technology for deployment across U.S. federal healthcare systems, integrated into GlobalMed's eNcounter® connected care platform.
4. Consumer Mobile App (Freemium): Free Canary Speech iOS and Android mobile apps enable self-serve use and brand funnel into API/enterprise offerings. A free 45-second voice-based check-in was launched for consumers.
5. Marketplace Transaction Revenue (Microsoft, Zoom): Revenue generated via partner app listings on Microsoft Marketplace (Dragon Copilot) and the Zoom App Marketplace, where clinicians and partner organizations procure Canary Ambient™ through marketplace channels.
6. Clinical Research & Validation Partnerships: Revenue from research collaborations with academic and clinical partners (e.g., Intermountain Health MS study, HaloScape Turkish GAD/MDD validation, Mayo Clinic, Beth Israel Deaconess, Harvard, NYU) for IRB-approved studies and population-specific validation.

Pricing tiers

Go-to-market motion5 records

Distribution channels7 records

Marketing channels8 records

Core offering

Canary Speech develops an API-first, AI-driven vocal biomarker platform that analyzes short speech samples (20-40 seconds) to detect cognitive and behavioral health conditions including anxiety, depression, MCI, Alzheimer's, Huntington's, Parkinson's, and Multiple Sclerosis. The flagship product, Canary Ambient™, provides real-time ambient listening during clinical and telehealth conversations to surface decision-support signals related to mood and cognitive status. The platform is sold to enterprise healthcare providers, payers, clinical trials, and contact centers, with extensions into consumer health via mobile apps and partner integrations.

Product overview

Canary Speech offers a unified vocal biomarker platform organized as a core API-first foundation with multiple modules and consumer-facing products. At the center is the Wellness API (Canary API), which powers Canary Express for rapid integration as well as the four core clinical modules: Canary Behavioral (for stress, anxiety, depression, and other behavioral conditions), Canary Cognitive (for MCI, Alzheimer's, Huntington's, Parkinson's, and multiple sclerosis), Canary Safety (for workplace aggression detection and clinician burnout prevention, including the Canary Ambient Continuous Monitoring variant), and Canary Wellness (for wellness, mood, energy, and stress monitoring). The flagship product, Canary Ambient™, is the industry's first ambient listening voice biomarker tool, providing real-time clinical decision support during patient-clinician conversations and integrating into partners such as Microsoft Dragon Copilot, Zoom (via the Zoom App Marketplace), Teladoc Health, GlobalMed, HaloScape, and JubileeTV. The consumer-facing Canary Speech Mobile App (iOS & Android) and the Free Voice-Based Check-In (45-second tool) extend Canary's clinically validated voice analysis outside of clinical settings, while Canary Express enables partners and developers to embed vocal biomarker scoring into their own applications within hours.

Differentiator

Problem solved

Functional benefit

Brands

• Canary Ambient: API-first ambient listening voice biomarker platform for real-time clinical decision support in healthcare and contact centers.
• Canary Ambient Continuous Monitoring
• Canary Behavioral
• Canary Cognitive
• Canary Safety
• Canary Wellness

Products and services

• Canary Ambient™ The industry's first ambient listening voice biomarker tool. Canary Ambient objectively detects cognitive and behavioral conditions by passively analyzing patient-clinician conversations in real time, providing decision-support signals related to mood and cognitive status without disrupting clinical workflows.
• Canary Ambient Continuous Monitoring Workplace safety variant of Canary Ambient that analyzes in-room audio in real time to detect verbal aggression, address workplace violence, and prevent clinician burnout in healthcare settings. Integrated into Teladoc Health's platform.
• Canary Wellness API (Canary API)

Quantifiable outcome

• 98% accuracy in detecting speech patterns for cognitive and behavioral health conditions (anxiety, depression, MCI, Alzheimer's, Huntington's, Parkinson's, MS)
• +6 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability10 records

Feature7 records

Partnerships

24 partnerships are on record, tiered core, flagship and minor.

• ZoomcoreTechnology or Integration · 23 June 2026Canary Ambient™ is available on the Zoom App Marketplace, giving clinicians access to real-time vocal biomarker insights during telehealth visits. Analyzes 2,500+ speech features for stress, depression, mood, anxiety, and neurodegenerative changes without disrupting clinical conversations.
• HaloScapecoreStrategic or Co-development Partner · 27 May 2026Strategic collaboration integrating Canary Speech's vocal biomarker technology into HaloScape's multi-modal health intelligence platform. Adds voice analysis for screening across mood, stress, vocal energy, wellness, and mild cognitive impairment. First IRB-approved clinical study will validate voice biomarkers in Turkish for generalized anxiety disorder and major depressive disorder. Expands Canary's global reach through new languages and populations.
• Ermita Alzheimer's Guatemala GroupcoreStrategic or Co-development Partner · 11 May 2026Collaboration to advance Spanish-language vocal biomarkers for Alzheimer's detection; supports validation in new populations and languages.
• GlobalMedcoreChannel Partner/ Reseller/ Distributor · 11 March 2026GlobalMed is an authorized reseller of Canary Speech's AI-powered vocal biomarker technology for deployment across U.S. federal healthcare systems. The technology is integrated into GlobalMed's eNcounter® connected care platform, analyzing 2,500+ digital biomarkers to identify patterns associated with stress, depression, mood disorders, Alzheimer's, Huntington's, and Parkinson's.
• Microsoft (Dragon Copilot)flagshipStrategic or Co-development Partner · 5 March 2026Canary Speech is a featured partner app on Microsoft Marketplace integrated into Dragon Copilot, the AI clinical assistant used by 100,000+ clinicians across the US, Canada, UK, Ireland, France, Germany, Austria, Belgium, and the Netherlands. Canary Ambient is showcased at HIMSS26 in the Microsoft Booth (#2812). Canary has earned the Microsoft Solutions Partner: Healthcare AI Certified Software designation.
• JubileeTVcoreStrategic or Co-development Partner · 25 February 2026First-of-its-kind partnership bringing Canary Speech's vocal biomarker technology into the consumer health market. Voice analysis is integrated into JubileeTV video calls to provide families with non-diagnostic insights into wellness, mood, stress, energy, and cognitive trends for aging loved ones, with privacy safeguards including opt-in consent, no voice storage, and no AI training on data.
• Intermountain Health (Intermountain Ventures)coreStrategic or Co-development Partner · 10 February 2026First IRB-approved study using AI voice analysis to identify early indicators of Multiple Sclerosis (MS), led by neurologist Dr. Timothy West. Targets 2.9 million people worldwide affected by MS and aims to develop a non-invasive screening tool.
• Coalition for Health AI (CHAI)coreOthers · 9 February 2026Canary Speech joined CHAI to advance responsible AI in healthcare, aligning with national recommendations for trustworthy healthcare AI. Active participation in CHAI workgroups such as Ambient AI and Chatbot initiatives; published CHAI Behavioral Health Applied Model Card.
• Teladoc HealthcoreOEM/ Whitelabel/ Licensing Partner · 15 October 2025Canary Ambient™ Continuous Monitoring is being integrated into Teladoc Health's platform to enhance workplace safety for hospital staff through real-time detection of verbal aggression, addressing workplace violence in healthcare settings.
• NYU (New York University)coreStrategic or Co-development Partner · 1 September 2025NYU is an esteemed research institution studying how AI voice biomarkers can help gauge pain in patients, in partnership with Canary Speech.
• University of Massachusetts Chan Medical SchoolcoreStrategic or Co-development Partner · 28 August 2025Research collaboration with Beth Israel Deaconess Medical Center on advancing Parkinson's detection with vocal biomarkers and speech foundation models.
• National Cerebral and Cardiovascular Center (NCVC), JapancoreStrategic or Co-development Partner · 24 June 2025Co-authored peer-reviewed study published in The Lancet Regional Health confirming Canary Speech's vocal biomarkers accurately detect mild cognitive impairment; 1,461 older adults studied.
• Nuvolis SolutionscoreStrategic or Co-development Partner · 1 June 2025Nuvolis Solutions delivers disruptive, high-impact tech solutions to rethink talent development and human management in the age of AI. Together with Canary, transforming how well-being and mental health are assessed in Latin America.
• Prism CareminorStrategic or Co-development Partner · 1 December 2024Prism Care manages patient health between provider visits by providing a comprehensive set of care services based on individuals' needs, in partnership with Canary Speech.
• Mayo ClinicflagshipStrategic or Co-development Partner · 1 November 2024Mayo Clinic is referenced as a strategic partner supporting Canary's clinical direction, with CMO Dr. Kang Hsu Jr. working closely with Mayo Clinic (alongside Microsoft, Samsung, and LG NOVA) on product development and research.
• SamsungflagshipStrategic or Co-development Partner · 1 November 2024Samsung is a featured strategic partner; Canary Speech showcases at HIMSS26 in the Samsung Booth (#4335). Samsung appears alongside Microsoft, LG NOVA, and Mayo Clinic as a key ecosystem partner enabling distribution across consumer devices and platforms.
• LG NOVAflagshipStrategic or Co-development Partner · 1 November 2024LG NOVA's goal is to improve quality of life by building new ventures that have a positive impact on the future of people and the planet, including cognitive and behavioral health conditions. LG NOVA also backs ReliefAI Health, a digital health venture Canary is connected to.
• Microsoft for HealthcarecoreTechnology or Integration · 1 November 2024Microsoft for Healthcare's goal is to accelerate innovation and improve healthcare experiences with AI-powered solutions, actionable insights, and trusted capabilities — directly aligned with Canary's platform.
• Life365coreStrategic or Co-development Partner · 1 November 2024Life365 provides virtual care, remote patient monitoring, and patient engagement solutions. The partnership integrates their technologies on the Microsoft Cloud for Healthcare platform to deliver scalable, proactive care to large patient populations. Canary CEO Henry O'Connell was part of a Life365 panel on voice/speech technology in January 2023.
• Hackensack Meridian HealthcoreStrategic or Co-development Partner · 1 November 2024Hackensack Meridian Health provides consolidated facility and community reporting for employee health and clinical patient monitoring in partnership with Canary.
• Harvard UniversityflagshipStrategic or Co-development Partner · 1 November 2024Harvard University is prioritizing innovation in healthcare to improve the wellness of physicians, mentors, and patients in partnership with Canary's cutting-edge technology. Beth Israel Deaconess Medical Center (Harvard Medical School's teaching hospital) has collaborated with Canary on Huntington's disease research.
• Veteran Business ProjectminorGTM or Marketing Partner · 1 November 2024The Veteran Business Project promotes military, veterans, and spouses small business ownership opportunities and overall health and wellbeing, partnering with Canary Speech.
• Ulster UniversityminorStrategic or Co-development Partner · 10 February 2022Strategic partnership with internationally recognized academic institution with a reputation for innovation and research in speech and language.
• Plug and Play JapanminorOthers · 12 October 2020Canary Speech was selected for Plug and Play Japan's Selection Day in two programs: IoT as well as Hardtech & Health.

Scale indicators13 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Sonde Health: Sonde Health develops a vocal biomarker platform for mental and respiratory health conditions using short voice samples. It is the closest direct peer to Canary Speech, competing in vocal biomarker analysis for behavioral and cognitive health with API-first delivery to enterprise health and wellness customers.
• Ellipsis Health: Ellipsis Health applies machine learning to vocal biomarkers to detect anxiety and depression, primarily for health systems and payers. It is a direct peer in the vocal biomarker-for-mental-health space, sharing target buyers (health plans, providers) and an evidence-led, API-integrated model.
• Winterlight Labs: Winterlight Labs analyzes speech and language to detect and monitor cognitive and mental health conditions, with a focus on clinical trials and CNS drug development. It is a direct peer in the vocal biomarker-for-cognitive-health segment, sharing pharmaceutical trial customers and academic validation partners.
• Kintsugi: Kintsugi uses voice biomarker technology to detect signs of depression and anxiety from short voice clips, sold into health plans, telehealth, and employers. It is a direct peer in API-based vocal mental health screening, overlapping with Canary's behavioral health use case.
• Aural Analytics: Aural Analytics builds clinical-grade speech analytics (Speech Vitals) to assess neurological and respiratory health from voice. It is a direct peer in clinical vocal biomarker analytics for neurological disease, including ALS and Parkinson's, sharing clinical trial and health system buyers with Canary.
• Modality.AI: Modality.AI provides AI-driven multimodal assessment agents that analyze speech, facial expression, and cognition for clinical trials and telehealth. It is a direct peer in AI-based speech and language assessment for neurological and psychiatric conditions, with overlapping clinical trial customers.

Emerging players

• Cogito (Cogito Corp): Cogito applies real-time voice AI to analyze customer and patient calls, with deep roots in behavioral analytics for contact centers and behavioral health. It overlaps with Canary's contact center and behavioral health use cases but is more established in customer experience than in clinical vocal biomarker diagnostics.
• Hume AI: Hume AI builds a voice and emotion AI platform measuring expression, tone, and well-being from speech, with API access for developers. It is an emerging player overlapping with Canary's vocal wellness and emotion analytics, but with a broader API-first developer focus rather than clinical-validated condition detection.

Broad incumbents

• Microsoft (Nuance / Dragon Copilot): Microsoft's Nuance-built Dragon Copilot is the ambient clinical AI platform in which Canary Ambient is embedded. While it is also a partner, Nuance owns foundational speech recognition IP and broader healthcare AI capabilities that overlap with and could subsume parts of Canary's functionality over time.
• Amazon (AWS HealthScribe / Comprehend Medical): Amazon (via AWS HealthScribe and Comprehend Medical) provides clinical speech AI services that compete at the ASR and ambient documentation layer underlying Canary's applications. It is a broad incumbent with deep voice AI infrastructure that can replicate or bundle vocal biomarker capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/in/henryjoconnell
• Xx.com/canaryspeech

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canary Speech